Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer
HS3ST2、SEPTIN9 和 SLIT2 启动子高甲基化联合 FGFR3 突变可作为诊断和监测低危或高危非肌层浸润性膀胱癌患者的敏感/特异的尿液检测方法。
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-016-2748-5
Roperch, Jean-Pierre; Grandchamp, Bernard; Desgrandchamps, François; Mongiat-Artus, Pierre; Ravery, Vincent; Ouzaid, Idir; Roupret, Morgan; Phe, Véronique; Ciofu, Calin; Tubach, Florence; Cussenot, Olivier; Incitti, Roberto